Wilson's disease. Update of a systemic disorder with protean manifestations.

In Wilson's disease, a genetic defect in a copper transporter causes defective incorporation of copper into apo-ceruloplasmin and the failure to excrete copper into bile. Copper accumulated in hepatocytes generates damage via reactive oxygen species. Release of copper from necrotic hepatocytes leads to damage of other tissues, including the brain, urinary tract, red blood cells, heart, endocrine glands, skin, pancreas, bones, and joints. Treatment is designed to chelate the excess copper for urinary excretion, prevent copper absorption, and render tissue copper nontoxic. Liver transplantation, with replacement of the defective hepatic gene, may be necessary in some cases.

[1]  A. Aisen,et al.  Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients. , 1994, Archives of neurology.

[2]  J M Walshe,et al.  Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients. , 1989, The Quarterly journal of medicine.

[3]  J. Ironside,et al.  An unusual case of Wilson's disease. , 1985, The Quarterly journal of medicine.

[4]  Stephan Nussberger,et al.  Cloning and characterization of a mammalian proton-coupled metal-ion transporter , 1997, Nature.

[5]  Jingshi Wu,et al.  The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene , 1994, Nature Genetics.

[6]  B. Walia,et al.  Fulminant hepatic failure and acute intravascular haemolysis as presenting manifestations of Wilson's disease in young children , 1992, Journal of gastroenterology and hepatology.

[7]  B. Portmann,et al.  Fulminant hepatic failure resulting from coexistent Wilson's disease and hepatitis E. , 1994, Gut.

[8]  R. Willson,et al.  Unmeasurable serum alkaline phosphatase activity in wilson's disease associated with fulminant hepatic failure and hemolysis , 1987, Hepatology.

[9]  E. Dickson,et al.  Pigmented corneal rings in non-Wilsonian liver disease. , 1977, Annals of internal medicine.

[10]  J. Cuthbert Iron, HFE, and hemochromatosis update. , 1997, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[11]  U. Landegren,et al.  Efficient detection of mutations in Wilson disease by manifold sequencing. , 1996, Genomics.

[12]  J. Gitlin,et al.  Expression of the Wilson disease gene is deficient in the Long-Evans Cinnamon rat. , 1994, The Biochemical journal.

[13]  D. Carnes,et al.  Hypoparathyroidism in Wilson's disease. , 1983, The New England journal of medicine.

[14]  J. Peppercorn,et al.  The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene , 1993, Nature Genetics.

[15]  L. Cavalli-Sforza,et al.  Wilson's disease in Israel: a genetic and epidemiological study , 1990, Annals of human genetics.

[16]  T. Dening,et al.  Wilson's disease. Psychiatric symptoms in 195 cases. , 1989, Archives of general psychiatry.

[17]  B. Hoppe,et al.  Hypercalciuria and Nephrocalcinosis, a Feature of Wilson’s Disease , 1993 .

[18]  C. Datz,et al.  Detection of the His1069Gln Mutation in Wilson Disease by Rapid Polymerase Chain Reaction , 1997, Annals of Internal Medicine.

[19]  I. Sternlieb,et al.  The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. , 1987, New England Journal of Medicine.

[20]  J. Mason,et al.  The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy. , 1992, The Journal of laboratory and clinical medicine.

[21]  J. Walshe,et al.  Chelation treatment of neurological Wilson's disease. , 1993, The Quarterly journal of medicine.

[22]  I. Sternlieb,et al.  Morphologic and chemical studies on a murine mutation (toxic milk mice) resulting in hepatic copper toxicosis. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[23]  E. Cauza,et al.  Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. , 1997, Journal of hepatology.

[24]  N. Takeichi,et al.  Prevention of spontaneous hepatocellular carcinoma in long‐evans cinnamon rats with hereditary hepatitis by th administration of d‐penicillamine , 1993, Hepatology.

[25]  R. Hu Severe spinal degeneration in Wilson's disease. , 1994, Spine.

[26]  S. Virgiliis,et al.  Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. , 1995, American journal of human genetics.

[27]  D. Frommer Urinary copper excretion and hepatic copper concentrations in liver disease. , 1981, Digestion.

[28]  A. Schäffer,et al.  Biochemistry of metallothionein. , 1988, Biochemistry.

[29]  I. Sternlieb,et al.  The role of radiocopper in the diagnosis of Wilson's disease. , 1979, Gastroenterology.

[30]  D W Cox,et al.  The toxic milk mouse is a murine model of Wilson disease. , 1996, Human molecular genetics.

[31]  J. Polio,et al.  Hepatocellular Carcinoma in Wilson's Disease Case Report and Review of the Literature , 1989, Journal of clinical gastroenterology.

[32]  H. Schumacher,et al.  The arthropathy of Wilson's disease: clinical and pathologic features. , 1988, The Journal of rheumatology.

[33]  E. Dickson,et al.  Diagnosis of Wilson's disease presenting as fulminant hepatic failure. , 1983, Gastroenterology.

[34]  J. Valentine,et al.  BIOCHEMISTRY: Delivering Copper Inside Yeast and Human Cells , 1997 .

[35]  K. Ishak,et al.  Histology of the liver in Wilson's disease: a study of 34 cases. , 1980, American journal of clinical pathology.

[36]  Y. Shoenfeld,et al.  Acute varicella infection heralding Wilsonian crisis. , 1994, Journal of clinical gastroenterology.

[37]  R. Klausner,et al.  Biochemical Characterization of the Wilson Disease Protein and Functional Expression in the Yeast Saccharomyces cerevisiae * , 1997, The Journal of Biological Chemistry.

[38]  R. Klausner,et al.  Identification and Functional Expression of HAH1, a Novel Human Gene Involved in Copper Homeostasis* , 1997, The Journal of Biological Chemistry.

[39]  P. Lockhart,et al.  Ligand‐regulated transport of the Menkes copper P‐type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking. , 1996, The EMBO journal.

[40]  D. Danks Disorders of copper transport , 1989 .

[41]  Burton Combes,et al.  Low serum alkaline phosphatase activity in Wilson's disease , 1986, Hepatology.

[42]  J. Walshe TREATMENT OF WILSON'S DISEASE WITH TRIENTINE (TRIETHYLENE TETRAMINE) DIHYDROCHLORIDE , 1982, The Lancet.

[43]  M. Sato,et al.  Inhibition of the copper incorporation into ceruloplasmin leads to the deficiency in serum ceruloplasmin activity in Long-Evans cinnamon mutant rat. , 1993, The Journal of biological chemistry.

[44]  T. Gilliam,et al.  Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. , 1997, American journal of human genetics.

[45]  E. D. Harris Copper Transport: An Overview , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[46]  Hogland Hc,et al.  Hematologic (cytopenic) manifestations of Wilson's disease (hepatolenticular degeneration). , 1978 .

[47]  J. Lau,et al.  Wilson's disease: 35 years' experience. , 1990, The Quarterly journal of medicine.

[48]  P. Wong,et al.  Primary hepatocellular carcinoma associated with Wilson's disease in a young woman. , 1985, Postgraduate medical journal.

[49]  E. Stewart,et al.  Polymorphic microsatellites and Wilson disease (WD). , 1993, American journal of human genetics.

[50]  M. Frydman,et al.  Endocrine studies of the ovulatory disturbances in Wilson’s disease (hepatolenticular degeneration) , 1987 .

[51]  Scheinberg Ih Wilson's disease. , 1981 .

[52]  I. Sternlieb,et al.  Pleiotropic effect of LEC mutation: a rodent model of Wilson's disease. , 1993, The American journal of physiology.

[53]  D. Watkin,et al.  REHABILITATION IN SCHIZOPHRENIA. , 1965, Lancet.

[54]  J. Cuthbert,et al.  Wilson's disease: a new gene and an animal model for an old disease. , 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[55]  T. Gilliam,et al.  Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. , 1994, Human molecular genetics.

[56]  I. Sternlieb,et al.  Is non-Indian childhood cirrhosis caused by excess dietary copper? , 1994, The Lancet.

[57]  J. Walshe,et al.  Wilson's disease: the problem of delayed diagnosis. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[58]  D. Cox,et al.  The Wilson disease gene: spectrum of mutations and their consequences , 1995, Nature Genetics.

[59]  J. Valentine,et al.  Delivering Copper Inside Yeast and Human Cells , 1997, Science.

[60]  B. Portmann,et al.  Hepatic morphology and histochemistry of Wilson's disease presenting as fulminant hepatic failure: a study of 11 cases , 1989, Histopathology.

[61]  T. Lyon,et al.  Copper associated childhood cirrhosis. , 1994, Gut.

[62]  N. Chu,et al.  Geographic variations in Wilson's disease , 1993, Journal of the Neurological Sciences.

[63]  Shin Lin,et al.  Metal ion chaperone function of the soluble Cu(I) receptor Atx1. , 1997, Science.

[64]  R. Steinert,et al.  Pseudo-Kayser-Fleischer ring of the cornea associated with non-Wilsonian liver disease. A case report and literature review. , 1993, Cornea.

[65]  J. Rommens,et al.  The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene , 1993, Nature Genetics.

[66]  M. Akil,et al.  The psychiatric presentations of Wilson's disease. , 1991 .

[67]  J. Gitlin,et al.  Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. , 1996, Human molecular genetics.

[68]  J. Walshe,et al.  DIAGNOSIS AND TREATMENT OF PRESYMPTOMATIC WILSON'S DISEASE , 1988, The Lancet.

[69]  J. Willeit,et al.  Copper-induced acute rhabdomyolysis in Wilson's disease. , 1995, Gastroenterology.

[70]  D. Glerum,et al.  Isolation of a cDNA encoding the human homolog of COX17, a yeast gene essential for mitochondrial copper recruitment , 1997, Human Genetics.

[71]  D. Danks,et al.  Wilson's disease in adults with cirrhosis but no neurological abnormalities. , 1990, BMJ.

[72]  Bing Zhou,et al.  hCTR1: a human gene for copper uptake identified by complementation in yeast. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[73]  M. Frydman Genetic aspects of Wilson's disease , 1990, Journal of gastroenterology and hepatology.

[74]  J. Gitlin,et al.  Biochemical characterization and intracellular localization of the Menkes disease protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[75]  P. Kuan Cardiac Wilson's disease. , 1987, Chest.

[76]  G. Brewer,et al.  Diagnosis and characterization of presymptomatic patients with Wilson's disease and the use of molecular genetics to aid in the diagnosis. , 1991, The Journal of laboratory and clinical medicine.

[77]  A. Giagheddu,et al.  Epidemiologic study of hepatolenticular degeneration (Wilson's disease) in Sardinia (1902–1983) , 1985, Acta neurologica Scandinavica.

[78]  J. Juyn,et al.  H714Q mutation in Wilson disease is associated with late, neurological presentation. , 1995, Journal of medical genetics.

[79]  R. Casareno,et al.  The Copper Chaperone for Superoxide Dismutase* , 1997, The Journal of Biological Chemistry.

[80]  I. Sternlieb,et al.  Liver transplantation for Wilson's disease: Indications and outcome , 1994, Hepatology.

[81]  B. Combes,et al.  DETECTION OF THE HETEROZYGOUS CARRIER OF THE WILSON'S DISEASE GENE. , 1961, The Journal of clinical investigation.

[82]  H. Cheong,et al.  Recurrent Hypokalemic Muscle Weakness as an Initial Manifestation of Wilson’s Disease , 1996 .

[83]  R. Calne,et al.  Reversal of severe neurological manifestations of Wilson's disease following orthotopic liver transplantation. , 1987, The Quarterly journal of medicine.

[84]  Y. Niitsu,et al.  Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats. , 1996, The Journal of clinical investigation.

[85]  M. Suzuki,et al.  Impaired Hepatic Copper Homeostasis in Long-Evans Cinnamon Rats: Reduced Biliary Excretion of Copper , 1994, Pediatric Research.

[86]  R. Williams,et al.  Wilson's disease: clinical presentation and use of prognostic index. , 1986, Gut.

[87]  S. Packman,et al.  Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper–transporting ATPase , 1993, Nature Genetics.

[88]  J. Gitlin,et al.  Functional Expression of the Menkes Disease Protein Reveals Common Biochemical Mechanisms Among the Copper-transporting P-type ATPases* , 1998, The Journal of Biological Chemistry.

[89]  N. A. Holtzman,et al.  Studies on the rate of release and turnover of ceruloplasmin and apoceruloplasmin in rat plasma. , 1970, The Journal of biological chemistry.

[90]  Akinori Nakamura,et al.  A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans , 1995, Nature Genetics.

[91]  A. Odermatt,et al.  Copper pumping ATPases: Common concepts in bacteria and man , 1994, FEBS letters.

[92]  L. Deecke,et al.  Wilson's disease , 1993, Neurology.

[93]  G. Mieli-Vergani,et al.  Failure of simple biochemical indexes to reliably differentiate fulminant wilson's disease from other causes of fulminant liver failure , 1992, Hepatology.

[94]  J. Walshe,et al.  Liver copper concentration in Wilson‘s disease: Effect of treatment with ‘anti‐copper’ agents , 1990, Journal of gastroenterology and hepatology.

[95]  S. Govindarajan,et al.  Hepatocellular carcinoma in a case of Wilson's disease. , 2008, Liver.

[96]  R. MacGillivray,et al.  Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[97]  H. Rauch Toxic milk, a new mutation affecting cooper metabolism in the mouse. , 1983, The Journal of heredity.

[98]  S. Sherlock,et al.  Histological demonstration of copper and copper-associated protein in chronic liver diseases. , 1978, Journal of clinical pathology.

[99]  T. Sugimura,et al.  Inhibition of hereditary hepatitis and liver tumor development in Long‐Evans cinnamon rats by the copper‐chelating agent trientine dihydrochloride , 1996, Hepatology.

[100]  J. Walshe,et al.  Copper: Its Role in the Pathogenesis of Liver Disease , 1984, Seminars in liver disease.

[101]  Ø. Aagenæs HEREDITARY RECURRENT CHOLESTASIS WITH LYMPHOEDEMA–TWO NEW FAMILIES , 1974 .

[102]  S. Nakada,et al.  Wilson's disease presenting as symptomatic urolithiasis: a case report and review of the literature. , 1994, The Journal of urology.

[103]  Y. Li,et al.  Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease. , 1991, The Journal of clinical investigation.

[104]  A. Członkowska,et al.  Late onset of Wilson's disease. Report of a family. , 1981, Archives of neurology.

[105]  W. Gahl,et al.  Indian childhood cirrhosis in an American child. , 1992, Gastroenterology.

[106]  M. Mori,et al.  The LEC rat: a model for human hepatitis, liver cancer, and much more. , 1994, The American journal of pathology.

[107]  J. Roh,et al.  Initial and follow‐up brain MRI findings and correlation with the clinical course in Wilson's disease , 1994, Neurology.

[108]  C. Seymour,et al.  Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin , 1996, European journal of clinical investigation.

[109]  R. Palmiter,et al.  A murine model of Menkes disease reveals a physiological function of metallothionein , 1996, Nature Genetics.

[110]  K. Schärer,et al.  Proteinuria and other renal functions in Wilson’s disease , 1997, Pediatric Nephrology.

[111]  J. Walshe The management of pregnancy in Wilson's disease treated with trientine. , 1986, The Quarterly journal of medicine.

[112]  M. Schilsky Wilson Disease: Genetic Basis of Copper Toxicity and Natural History , 1996, Seminars in liver disease.

[113]  D. V. van Thiel,et al.  Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. , 1991, Gastroenterology.

[114]  H. Wahner,et al.  Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case. , 1975, Mayo Clinic proceedings.